Your browser doesn't support javascript.
loading
Comparative Cost-Effectiveness Analysis of Adding Twice-Daily Exenatide To Insulin Glargine Versus Adding Insulin Lispro To Treat Type 2 Diabetes In Spain.
Sánchez-Covisa, J; Capel, M; Baeten, S; Verheggen, B G.
Affiliation
  • Sánchez-Covisa J; AstraZeneca, Madrid, Spain.
  • Capel M; AstraZeneca, Madrid, Spain.
  • Baeten S; Pharmerit International, Rotterdam, The Netherlands.
  • Verheggen BG; Pharmerit International, Rotterdam, The Netherlands.
Value Health ; 17(7): A349-50, 2014 Nov.
Article in En | MEDLINE | ID: mdl-27200673
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Value Health Journal subject: FARMACOLOGIA Year: 2014 Document type: Article Affiliation country: Spain